Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cost and utilization of healthcare services for persons with diabetes.
Reynolds EL, Mizokami-Stout K, Putnam NM, Banerjee M, Albright D, Ang L, Lee J, Pop-Busui R, Feldman EL, Callaghan BC. Reynolds EL, et al. Among authors: mizokami stout k. Diabetes Res Clin Pract. 2023 Nov;205:110983. doi: 10.1016/j.diabres.2023.110983. Epub 2023 Oct 27. Diabetes Res Clin Pract. 2023. PMID: 37890702
Improved Glycemia with Hybrid Closed-Loop Versus Continuous Subcutaneous Insulin Infusion Therapy: Results from a Randomized Controlled Trial.
Garg SK, Grunberger G, Weinstock R, Lawson ML, Hirsch IB, DiMeglio LA, Pop-Busui R, Philis-Tsimikas A, Kipnes M, Liljenquist DR, Brazg RL, Kudva YC, Buckingham BA, McGill JB, Carlson AL, Criego AB, Christiansen MP, Kaiserman KB, Griffin KJ, Forlenza GP, Bode BW, Slover RH, Keiter A, Ling C, Marinos B, Cordero TL, Shin J, Lee SW, Rhinehart AS, Vigersky RA; Adult and Pediatric MiniMed™ HCL Outcomes 6-month RCT: HCL versus CSII Control Study Group. Garg SK, et al. Diabetes Technol Ther. 2023 Jan;25(1):1-12. doi: 10.1089/dia.2022.0421. Epub 2022 Dec 20. Diabetes Technol Ther. 2023. PMID: 36472543 Free PMC article. Clinical Trial.
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
Das Pradhan A, Glynn RJ, Fruchart JC, MacFadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ, Brinton EA, Eckel RH, Elam MB, Felicio JS, Ginsberg HN, Goudev A, Ishibashi S, Joseph J, Kodama T, Koenig W, Leiter LA, Lorenzatti AJ, Mankovsky B, Marx N, Nordestgaard BG, Páll D, Ray KK, Santos RD, Soran H, Susekov A, Tendera M, Yokote K, Paynter NP, Buring JE, Libby P, Ridker PM; PROMINENT Investigators. Das Pradhan A, et al. N Engl J Med. 2022 Nov 24;387(21):1923-1934. doi: 10.1056/NEJMoa2210645. Epub 2022 Nov 5. N Engl J Med. 2022. PMID: 36342113 Clinical Trial.
The conundrum of diabetic neuropathies-Past, present, and future.
Ang L, Mizokami-Stout K, Eid SA, Elafros M, Callaghan B, Feldman EL, Pop-Busui R. Ang L, et al. Among authors: mizokami stout k. J Diabetes Complications. 2022 Nov;36(11):108334. doi: 10.1016/j.jdiacomp.2022.108334. Epub 2022 Oct 7. J Diabetes Complications. 2022. PMID: 36306721 Free PMC article. Review.
Neuropsychological Outcomes in Individuals With Type 1 and Type 2 Diabetes.
Putnam NM, Reynolds EL, Banerjee M, Mizokami-Stout K, Albright D, Lee J, Pop-Busui R, Feldman EL, Callaghan BC. Putnam NM, et al. Among authors: mizokami stout k. Front Endocrinol (Lausanne). 2022 Mar 4;13:834978. doi: 10.3389/fendo.2022.834978. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35317223 Free PMC article.
Continuous Glucose Monitoring With Low-Carbohydrate Nutritional Coaching to Improve Type 2 Diabetes Control: Randomized Quality Improvement Program.
Griauzde DH, Ling G, Wray D, DeJonckheere M, Mizokami Stout K, Saslow LR, Fenske J, Serlin D, Stonebraker S, Nisha T, Barry C, Pop-Busui R, Sen A, Richardson CR. Griauzde DH, et al. Among authors: mizokami stout k. J Med Internet Res. 2022 Feb 2;24(2):e31184. doi: 10.2196/31184. J Med Internet Res. 2022. PMID: 35107429 Free PMC article. Clinical Trial.
34 results